Single-dose PCV13 immunogenic, safe in pediatric oncology
(HealthDay)—For pediatric and adolescent oncology patients, a single-dose 13-valent pneumococcal conjugate vaccine (PCV13) is safe and immunogenic, according to a study published online July 11 in Cancer.
Jul 19, 2017
0
2